Publications by authors named "Nika Adham"

Claim this Profile
P
Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders.
Jan Kehr, Fu-Hua Wang, Fumio Ichinose, Shimako Yoshitake, Bence Farkas, Nika Adham

Front Psychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Viktor Román, Nika Adham, Andrew G Foley, Lynsey Hanratty, Bence Farkas

Psychopharmacology (Berl)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin receptor neurotransmission in the hippocampus.
Mostafa El Mansari, Mohammad Ebrahimzadeh, Rami Hamati, Chidibere M Iro, Bence Farkas, Nika Adham

J Psychopharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel antipsychotic cariprazine stabilizes gamma oscillations in rat hippocampal slices.
Maria A Meier, Clement E Lemercier, Christoph Kulisch, Béla Kiss, Balázs Lendvai, Nika Adham

Br J Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Dopamine D Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens.
Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham

J Pharmacol Exp Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel atypical antipsychotic cariprazine demonstrates dopamine D receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.
Sarah Delcourte, Charles R Ashby, Renaud Rovera, Béla Kiss, Nika Adham

CNS Neurosci Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of 5-HT and 5-HT Receptors but Not -Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain In Vivo.
Anna Herman, Mostafa El Mansari, Nika Adham, Béla Kiss, Bence Farkas

Mol Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task.
Samuel A Barnes, Jared W Young, Athina Markou, Nika Adham, István Gyertyán

Psychopharmacology (Berl)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task.
Samuel A Barnes, Jared W Young, Athina Markou, Nika Adham, István Gyertyán

Psychopharmacology (Berl)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
Jan Kehr, Takashi Yoshitake, Fumio Ichinose, Shimako Yoshitake, Béla Kiss, Nika Adham

Psychopharmacology (Berl)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine.
Yong Kee Choi, Nika Adham, Béla Kiss, István Gyertyán, Frank I Tarazi

CNS Spectr· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
Vanja Duric, Mounira Banasr, Tina Franklin, Ashley Lepack, Nika Adham

Int J Neuropsychopharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
Ragy R Girgis, Mark Slifstein, Deepak D'Souza, Yih Lee, Antonia Periclou, Nika Adham

Psychopharmacology (Berl)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
David J G Watson, Madeleine V King, Istvan Gyertyán, Béla Kiss, Nika Adham

Eur Neuropsychopharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Jo C Neill, Ben Grayson, Béla Kiss, István Gyertyán, Paul Ferguson, Nika Adham

Eur Neuropsychopharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine delays ouabain-evoked epileptiform spikes and loss of activity in rat hippocampal slices.
Rif S El-Mallakh, Ralphiel S Payne, Avital Schurr, Yonglin Gao, Zhemin Lei, Nika Adham

Psychiatry Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions.
Yonglin Gao, Sean Peterson, Bernard Masri, M Tyler Hougland, Nika Adham

Pharmacol Res Perspect· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression.
Mariusz Papp, Piotr Gruca, Magdalena Lasoń-Tyburkiewicz, Nika Adham, Béla Kiss

Behav Pharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of cariprazine exposure on dopamine receptor subtypes.
Yong Kee Choi, Nika Adham, Béla Kiss, István Gyertyán, Frank I Tarazi

CNS Spectr· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
Miklós Tóth, Andrea Varrone, Carsten Steiger, István Laszlovszky, Attila Horváth, Nika Adham

Synapse· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse.
Ross Zimnisky, Gloria Chang, István Gyertyán, Béla Kiss, Nika Adham

Psychopharmacology (Berl)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
Béla Kiss, Attila Horváth, Zsolt Némethy, Eva Schmidt, István Laszlovszky, Nika Adham

J Pharmacol Exp Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
Deborra Mullins, Nika Adham, David Hesk, Yusheng Wu, Joseph Kelly

Eur J Pharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis